uniQure N.V.·4

Jun 12, 5:08 PM ET

Balachandran Madhavan 4

4 · uniQure N.V. · Filed Jun 12, 2026

Research Summary

AI-generated summary of this filing

Updated

uniQure (QURE) Director Balachandran Madhavan Sells Shares, Receives RSUs

What Happened

  • Balachandran Madhavan, a director of uniQure N.V. (QURE), had three reported transactions: he was granted 7,550 restricted share units (RSUs) and a 13,980-share derivative award on 2026-06-10 (both reported at $0.00 acquisition price), and 1,993 shares were sold on 2026-06-11 in an open-market disposal for a weighted average price of $27.06, totaling $53,931. The sale was executed automatically to cover withholding taxes and was not a discretionary trade.

Key Details

  • Grant dates: 2026-06-10 — 7,550 RSUs (Acquired, $0.00); 2026-06-10 — 13,980 derivative award (Acquired, $0.00).
  • Sale date: 2026-06-11 — 1,993 shares sold (Open market) at a weighted avg price of $27.06; total proceeds ~$53,931. Price range for the sale: $26.92–$27.25.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Notable footnotes:
    • F1: 7,550 RSUs represent contingent rights to one ordinary share per RSU; vest 100% on the first anniversary of grant, subject to continued service.
    • F4: The 13,980 derivative award (stock option) vests 100% on the first anniversary of grant, subject to continued service.
    • F2: The 1,993 shares were sold automatically upon RSU vesting to cover estimated withholding taxes — not a discretionary sale.
    • F3: Weighted-average sale price reported; the filer can provide per-trade prices on request.
  • Filing timeliness: Form 4 filed 2026-06-12 for transactions on 2026-06-10 and 2026-06-11; appears timely (not indicated as late).

Context

  • The sale appears routine tax-withholding related to RSU vesting rather than a voluntary divestiture, so it is less indicative of a change in insider sentiment. The grants are subject to one-year cliff vesting; no immediate exercise or cashless sale of options is reported.

Insider Transaction Report

Form 4
Period: 2026-06-10
Transactions
  • Award

    Ordinary Shares

    [F1]
    2026-06-10+7,55045,247 total
  • Sale

    Ordinary Shares

    [F2][F3]
    2026-06-11$27.06/sh1,993$53,93143,254 total
  • Award

    Stock Option (Right to Buy)

    [F4]
    2026-06-10+13,98013,980 total
    Exercise: $26.82Exp: 2036-06-10Ordinary Shares (13,980 underlying)
Footnotes (4)
  • [F1]Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
  • [F2]The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
Signature
/s/ Christian Klemt, Attorney-in-Fact|2026-06-12

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT